id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-P-0182-0002,FDA,FDA-2007-P-0182,FDA Center for Drug and Evaluation Research Response to Sanofi Aventis - Letter,Other,LET-Letter,2007-12-04T05:00:00Z,2007,12,,,2008-07-15T23:43:46Z,,0,0,090000648042a706
FDA-2007-P-0182-0001,FDA,FDA-2007-P-0182,Acknowledgement Letter to Sanofi Aventis U.S. Inc.,Other,ACK-Acknowledgement Letter,2007-06-08T04:00:00Z,2007,6,,,2008-07-15T23:31:55Z,,0,0,090000648042a6f7